#sickle cell disease

#sickle cell disease

For a decade after its discovery, CRISPR gene editing was stuck on the cusp of transforming medicine. Then, in 2023, scientists started using it on sickle-cell disease, and Victoria Gray, a patient who lived with constant pain-like lightning inside her body, she has said -got the first-ever FDA-approved CRISPR gene-editing treatment. Her symptoms vanished; so did virtually everyone else's in the clinical trial she was a part of.

"Hi, and welcome. My name is Xaia, and I'm your mental health ally. How can I help?" The virtual reality experience provided comfort and relief for users.